g 10

Cross-linked dextran G 10 is a weak cation exchanger and hydrophilic gel, suitable for use as a gel filtration medium (spherical proteins separation range: >700 Da; polysaccharides separation range: >700 Da).

Cross-linked dextran G 100, coarse, comprises microspheres with an average particle size of D50 of 190-210 μm.

3'-Amino-Modifier C7 CPG 1000 is a reagent used in biochemical reactions.

Gel filtration medium G-100, a substance designed for protein purification, enables the separation and purification of proteins through gel filtration.

DPPE-PEG1000 is a PEG lipid functional end group used for synthesizing liposomes (LPs) and is instrumental in designing conjugated polymer nanoparticles. Liposome nanoparticles (LNPs), featuring biotin modification and carboxyl terminals, can further couple with other biomolecules. These functionalized nanoparticles are useful for the targeted labeling of specific cell proteins. By employing streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles can bind to biotinylated antibodies on cell surface receptors, enabling applications in fluorescence-based imaging and sensing.

18:0 mPEG1000 PE (ammonium) is a PEG-lipid functional end group utilized in the synthesis of liposomes (LPs) and in designing conjugated polymer nanoparticles. These liposome nanoparticles (LNPs), modified with biotin and carboxyl ends, can further couple with other biomolecules. Functionalized nanoparticles are applicable for targeted labeling of specific cellular proteins. With streptavidin as a linker, the biotinylated PEG-lipid conjugated polymer nanoparticles bind to biotinylated antibodies on cell surface receptors, offering utility in fluorescence-based imaging and sensing.

PLGA20000-PEG1000-NH2 is a reagent used in biochemical reactions.

PLGA20000-PEG10000-NH2 is a reagent used in biochemical reactions.

DMPE-PEG1000 is a PEG lipid functional end group used for liposome (LPs) synthesis, instrumental in designing conjugated polymer nanoparticles. Liposome nanoparticles (LNPs) can undergo further coupling with other biomolecules via biotin modification and carboxyl terminals. These functionalized nanoparticles are applicable for targeted labeling of specific cell proteins. Using streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles can bind to biotinylated antibodies on cell surface receptors, enabling utility in fluorescence-based imaging and sensing.

18:1 PEG1000 PE is a PEG-lipid functional end group used in the synthesis of liposomes (LPs) and for designing conjugated polymer nanoparticles. Liposome nanoparticles (LNPs) can be further coupled with other biomolecules through biotin modification and a carboxyl end. Functionalized nanoparticles are applicable for the targeted labeling of specific cell proteins. Using streptavidin as a linker, biotin-modified PEG-lipid conjugated polymer nanoparticles can bind with biotinylated antibodies on cell surface receptors, facilitating fluorescence-based imaging and sensing applications.

PLGA1000-PEG1000-VS (PLGA1000-PEG1000-Vinylsulfone) is an amphiphilic polymer. Due to its ability to self-assemble into discrete aggregates, it is utilized in drug delivery research.

PLGA2000-PEG1000-VS (PLGA2000-PEG1000-Vinylsulfone) is an amphiphilic polymer. Due to its ability to self-assemble into distinct aggregates, this type of polymer is useful in drug delivery research.

PLGA3000-PEG1000-VS (PLGA3000-PEG1000-Vinylsulfone) is an amphiphilic polymer. Such polymers are valuable for drug delivery research due to their ability to self-assemble into discrete aggregates.

PLGA4000-PEG1000-VS (PLGA4000-PEG1000-Vinylsulfone) is an amphiphilic polymer. Due to its capability to self-assemble into distinct aggregates, this type of polymer is valuable for drug delivery research.

PLGA5000-PEG1000-VS (PLGA5000-PEG1000-Vinylsulfone) is an amphiphilic polymer. These types of polymers are valuable in drug delivery research due to their ability to self-assemble into discrete aggregates.

PLLA10000-PEG1000-VS (PLLA10000-PEG1000-Vinylsulfone) is an amphiphilic polymer. These types of polymers are studied for drug delivery due to their ability to self-assemble into discrete aggregates.

PLLA1000-PEG1000-VS (PLLA1000-PEG1000-Vinylsulfone) is an amphiphilic polymer. Such polymers are utilized in drug delivery research due to their ability to self-assemble into discrete aggregates.

PLLA2000-PEG1000-VS (PLLA2000-PEG1000-Vinylsulfone) is an amphiphilic polymer. Due to its capability to self-assemble into discrete aggregates, this type of polymer is utilized in drug delivery research.

PLLA4000-PEG1000-VS (PLLA4000-PEG1000-Vinylsulfone) is an amphiphilic polymer. These types of polymers are utilized in drug delivery research due to their ability to self-assemble into distinct aggregates.

PLLA3000-PEG1000-VS (PLLA3000-PEG1000-Vinylsulfone) is an amphiphilic polymer. Due to its ability to self-assemble into discrete aggregates, such an amphiphilic polymer can be utilized in drug delivery research.

PLLA6000-PEG1000-PLLA6000 is an amphiphilic triblock polymer derived from polylactic acid, designed to enhance the specificity and cellular affinity of PLA-based biomaterials. It is applicable in drug delivery research.

PLLA8000-PEG1000-PLLA8000 is an amphiphilic triblock polymer derived from polylactic acid, enhancing the specificity and cell affinity of PLA-based biomaterials. It is applicable in drug delivery research.

PLLA5000-PEG1000-Thiol is a polylactic acid derivative capable of forming micelles in aqueous solutions, and it undergoes biodegradation through hydrolytic cleavage of ester bonds. PLLA5000-PEG1000-Thiol is utilized in drug delivery research.

PLLA4000-PEG1000-Thiol is a polylactic acid derivative that can form micelles in water and undergoes biodegradation through hydrolysis of ester bonds. This compound is applicable in studies related to drug delivery.